MedX Health ( (TSE:MDX) ) just unveiled an announcement.
MedX Health Corp. has announced an extension of its Non-Brokered Private Placement, allowing for further closings until June 6, 2025. The company aims to raise additional funds to support the development of its SIAscopy® on DermSecure® telemedicine platform and expand into the occupational health market. The initial closing raised $945,000, and the extension could potentially raise up to $1,555,000 more. This move is expected to enhance MedX’s market positioning and operational capabilities, with insiders potentially participating in the placement.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a prominent medical device and software company specializing in skin health. The company is known for its SIAscopy® on DermSecure® telemedicine platform, which uses advanced technology to provide non-invasive skin assessments. MedX’s products, including SIAMETRICS®, SIMSYS®, and MoleMate®, are approved for use in multiple countries, including Canada, the U.S., and the European Union.
Average Trading Volume: 77,781
Technical Sentiment Signal: Buy
Current Market Cap: C$21.44M
For detailed information about MDX stock, go to TipRanks’ Stock Analysis page.